(Q52166459)

26 April 2018

title

Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK-801. (English)

1 reference

26 April 2018

author name string

Jacobs PS

series ordinal

1

1 reference

26 April 2018

Taylor BM

series ordinal

2

1 reference

26 April 2018

Bardgett ME

series ordinal

3

1 reference

26 April 2018

publication date

1 July 2000

1 reference

26 April 2018

number of pages

5

1 reference

Developmental Brain Research

inferred from page(s)

published in

1 reference

26 April 2018

volume

122

1 reference

26 April 2018

issue

1

1 reference

26 April 2018

page(s)

91-95

1 reference

26 April 2018

Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Ontogeny of glycine-enhanced [3H]MK-801 binding to N-methyl-D-aspartate receptor-coupled ion channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Haloperidol blocks increased locomotor activity elicited by carbachol infusion into the ventral hippocampal formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Inhibition of long-term potentiation by NMDA-mediated nitric oxide release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Developmental expression, compartmentalization, and possible role in excitotoxicity of a putative NMDA receptor protein in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

The mystery of mammalian puberty: how much more do we know?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2800%2900059-6

7 January 2021

10.1016/S0165-3806(00)00059-6

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018